Find News

Filter articles

Applied Filters

Showing 1 to 10 of 2125 results

Edwards Lifesciences revives Fintiv challenge

US14-03-2023Muireann Bolger

Medtech company wins reversal of earlier ruling | Door opens to mount a challenge of controversial rule | USPTO director‘s updated guidelines influence court’s reasoning.

Don’t distort enablement law, Amgen tells SCOTUS

US09-03-2023Muireann Bolger

Sanofi and Regeneron accused of wanting to change patent system | The US Supreme Court will decide whether a controversial court decision should stand.

Gilead defeats immunity bid in hepatitis C patent case

US07-03-2023Muireann Bolger

The University of Minnesota had raised three key issues on appeal | Sovereign immunity was at the heart of the years-long dispute.

Genentech seeks ‘tens of millions in unpaid royalties’ in licence dispute

US07-03-2023Liz Hockley

The Roche subsidiary says the licensee owes payments on “stockpile” of MS drug Tysabri.

WIPO: Pharma patents dwindle against record total growth

International02-03-2023Sarah Speight

Health-related patents fell during 2022 against a backdrop of record global patents filed | Biotechnology was fastest growing field among Patent Cooperation Treaty applications | COVID-19 pandemic caused large falls in goods classes such as pharmaceuticals.

Jazz Pharma loses patent case over narcolepsy drug

US28-02-2023Liz Hockley

Court finds no method-of-use in patent claims | Judgment is a win for rival firm Avadel.

Trial set for Gilead HIV antitrust claims case

US23-02-2023Liz Hockley

Gilead, Johnson & Johnson and others will face trial in May | Class-action suit involves allegations of anticompetitive practices.

Sanofi backed by big pharma and more in SCOTUS clash

International21-02-2023Liz Hockley

Case focuses on the enablement scope of patents | Amici curiae argue Amgen patents are too broad | Pfizer | Eli Lilly | AstraZeneca| Sanofi | Genentech | Bayer | Gilead Sciences| Johnson & Johnson.

US govt wades into Moderna COVID row

US15-02-2023Staff Writer

The pharma company is accused of using patented tech for a drug-delivery system without authorisation | Moderna sought to escape the suit by claiming that its contract with the US government conferred immunity.

Federal Circuit rejects Dartmouth College bid to overturn patent ruling

US14-02-2023Staff Writer

Dietary supplements containing a form of vitamin B3 found in cow’s milk are unpatentable | Judge cites Myriad noting that the “act of isolating the NR compared to how NR naturally exists in milk is not sufficient, on its own, to confer patent eligibility”.

Showing 1 to 10 of 2125 results